Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Wolters Kluwer Completes First Group of Data Migrations for New Customers Converting to ProVation MD from Olympus EndoWorks

More Than 94,000 Examination Records at Three Facilities Migrated in Less Than 24 Hours

 

March 16, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, today announced it has successfully completed data migrations at three ProVation® MD Gastroenterology customer facilities that converted from Olympus® EndoWorks® in advance of its 2018 retirement. Wolters Kluwer signed agreements last year to replace Olympus EndoWorks with ProVation MD at 86 healthcare facilities.

The data migrations were conducted using the EndoWorks Export Tool developed by Olympus and licensed to Wolters Kluwer, a preferred replacement vendor. Use of the export tool in conjunction with its own proprietary data import tool enabled Wolters Kluwer to successfully migrate an average of nearly 32,000 examination records representing up to 10 years of patient data at each facility. The three data migrations were completed in less than 24 hours combined, with one migration taking just a single hour.

“The success of these data migrations is a key milestone that further solidifies our position as the leading vendor and product of choice for replacing Olympus EndoWorks,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “Access to the EndoWorks Export Tool is a key differentiator for us as only Olympus-preferred vendors can license the utility. Using the export tool and applying our years of expertise managing clinical data, we’ve proven the speed, accuracy and value of our EndoWorks data migration methodology.”

The only dedicated structured reporting and coding solution that provides clinically relevant, intuitive software for more accurate and complete documentation of procedures, ProVation MD Gastroenterology allows physicians to efficiently capture robust detail from even the most complex procedures. It then automatically generates clear, complete procedure notes and appropriate reimbursement codes, quickly, easily and without dictation. By automatically applying the reimbursement codes and disseminating critical procedural information, ProVation MD ensures appropriate payment, reduces costs and streamlines quality reporting while improving clinical communication and care coordination.

To lessen the impact on its customers as it phases out EndoWorks over three years, Olympus identified ProVation MD and one other software solution as recommended replacements. That means Wolters Kluwer is one of just two vendors able to license an Olympus-developed export utility to seamlessly migrate data from EndoWorks to ProVation MD.

Click here for more information on converting to ProVation MD from Olympus EndoWorks.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visithttp://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

March 16, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Wolters Kluwer to Showcase its Decision Support Solution for Improving Sepsis Outcomes at HIMSS16

MINNEAPOLIS–(BUSINESS WIRE)–The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, will showcase its cloud-based decision support platform for the improved diagnosis and treatment of sepsis in Booth #5537 at the HIMSS16 Conference & Exhibition. POC Advisor™, which reduced sepsis mortality by 53 percent at Huntsville Hospital, integrates and functions seamlessly with the clinical workflow, leveraging electronic alerts and patient-specific, evidence-based treatment advice to drive down sepsis rates.

In December 2015, Halifax Health, East Central Florida’s largest healthcare provider, decided to partner with Wolters Kluwer to adopt POC Advisor into its clinical workflow. Halifax, home to Florida’s largest emergency department (ED) with more than 116,000 emergency visits annually, will be the first to adopt POC Advisor for use in the ED.

“Administering early treatment is imperative to surviving sepsis; however, a number of other conditions present with similar symptoms, which makes diagnosis at the onset challenging.” said Zabrina Evens, M.D., Sepsis BPCI Medical Director for Halifax Health. “For example, in an emergency environment, especially one with a patient population as large as ours, it’s extremely difficult for clinicians to scrutinize the data necessary for early identification for every patient. Partnering with Wolters Kluwer provides our staff with the best opportunity to improve sepsis care and save patients’ lives.”

Sepsis is the deadliest condition treated in hospital critical care units, claiming approximately 258,000 lives in U.S. hospitals every year. At an estimated $20 billion annually, it is also the country’s most expensive condition to treat. The risk of death increases every hour sepsis goes untreated, making early identification crucial to improving outcomes.

POC Advisor uses automated, real-time surveillance that aggregates, normalizes and analyzes patient data from disparate clinical systems to deliver early sepsis alerts and treatment advice to clinicians via mobile devices and clinical portals. With hundreds of rules built into the platform to account for variables specific to individual patients, including comorbidities and medication abnormalities, POC Advisor ensures that alerts are both highly sensitive and specific.

“Diagnosing and treating sepsis is a formidable challenge for providers, especially at a time when clinicians’ responsibilities continue to become increasingly complex and demanding. POC Advisor leverages patient data within the EHR, using real-time analytics and delivering highly accurate alerts and medical advice directly to the point of care without disrupting the clinical workflow,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “POC Advisor exemplifies our commitment to improving the quality of care by providing latest tools and medical evidence to save lives.”

For a demonstration of POC Advisor, visit the Wolters Kluwer (Booth #5537) at the HIMSS16, taking place February 29-March 4 in Las Vegas.

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or@Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

February 25, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

medCPU Closes $8 Million Financing, Continues to Reinforce Leadership Position in Clinical Decision Support Market

NEW YORK, N.Y., July 14, 2015 – medCPU, Inc., a leader in enterprise clinical decision support solutions, announced today that it closed an $8 million financing round, consisting of $5 million series B-2 equity and $3 million in debt financing. The equity round was led by Merck Global Health Innovation Fund and New Richmond Ventures, and debt financing was provided by Silicon Valley Bank. This additional funding will enable medCPU to continue to assert its leadership position in the dynamic clinical decision support marketplace.

“We are driven by the confidence of our financial partners to further achieve our vision of changing the face of clinical decision support as it is known today,” said Sonia Ben-Yehuda, President and Co-Founder of medCPU, Inc. “In the past, the adoption of decision support has been stifled by outdated technologies that do not meet the needs of today’s clinicians. Unlike older, unreliable technologies that cause alert fatigue among clinicians, our solution delivers highly accurate and reliable decision support to clinicians at the point-of-care in real-time without disrupting their workflow.”

In a fast-paced environment where every detail is critical to a patient’s quality of care, real-time clinical decision support is a crucial component of a clinician’s workflow. The medCPU Advisor™, medCPU’s enterprise platform technology, acquires and processes both structured and unstructured data immediately as it is entered into a clinician’s Electronic Medical Record (EMR) system. The technology then assesses the data against best practice modules to provide the clinician with a holistic view of their patient and to ultimately provide highly accurate, real-time, reliable prompts at the point-of-care.

“We work with the most innovative companies, and those that have potential to transform the future of healthcare,” commented Michael Hanewich, Managing Director, Head of Life Science and Healthcare Venture Capital Relationships for Silicon Valley Bank. “The medCPU team has the vision and expertise to improve the accuracy and delivery of healthcare as it stands today.”

“Our technology is already being used by over 20,000 clinicians and a number of leading healthcare providers,” added Ms. Ben-Yehuda. ”This financing will help us to continue to grow our market share. We are excited about facilitating the move beyond antiquated, evidence-based reference tools to a new era of clinical decision support.”

medCPU’s solution is simple and seamless to deploy as it does not require integration into an EMR system or complex data connectivity to an interface engine. The medCPU Advisor™ enables healthcare providers to optimize investments already made in their EMRs. Running in the background of an EMR system unseen, the technology reads and captures data without disrupting a clinician’s workflow and only provides notifications when deviation from best practice care consideration occurs.

To meet the needs of different specialized health care organizations, medCPU delivers a wide range of customizable clinical and compliance decision support solutions, including modules for Obstetrics, Spine, Stroke, CHF, COPD, Value Based Purchasing, DRG’s, ICD-10, VTE Prophylaxis, Population Health, and in partnership with ILÚM Health Solutions™ (a subsidiary of Merck & Co., Inc. Kenilworth, NJ) is developing modules for Infectious Diseases such as Sepsis, Pneumonia and Urinary Tract Infection that also enable comprehensive Antimicrobial Stewardship.

About medCPU:
medCPU delivers accurate real-time enterprise decision support software and services through its proprietary Advisor technology. medCPU captures the complete clinical picture from clinicians’ free-text notes, dictations, discharge summaries and structured documentation entered into any Electronic Medical Record (EMR), and analyzes it against a growing library of best-practice content, generating real-time precise prompts for best care consideration. medCPU’s founding multi-disciplinary team has been pioneering new clinical decision support for nearly 20 years, delivering intelligent error reduction software systems to hospitals across the United States. medCPU’s applications include clinical and compliance support solutions. For more information, visit www.medCPU.com.

July 15, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Zoeticx Leverages Crowd Funding to Introduce TruRecord, Medical Prescribing Software That Will Address 2.2 Million Adverse Drug Reactions in U.S.

First EHR-integrated, Precise and Personalized, Mobile Platform to Leverage Advances in DNA Testing for Better Patient Outcomes and Lower Malpractice Payouts

June 29, 2015; San Jose, Calif — Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions.

The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr http://www.medstartr.com/projects/662-trurecord

TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts. CDC ranks this as the fourth highest cause of deaths in US. With 30 new medications introduced yearly and 25 percent of patients on multiple medications, the need is growing.  The CDC also ranks this as the fourth highest cause of death in the U.S. after heart disease, cancer and strokes.

TruRecord is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in 289 billion spent annually on malpractice payouts.

Breaking Through Drug Analysis Limitations

Through an intuitive visualization of drug-to-drug interactions, drug-to-allergy interactions, and drug to DNA metabolization, medical professionals can now create what-if scenarios for drug issues, enabling providers to personalize prescriptions. This capability breaks through providers’ drug analysis limitations and the burdensome task of scanning and searching text and tables to identify adverse reaction data which is often complex.

These scenarios can now also be more complete with accurate patient medical information from any facility, including integration from existing hospital EHR’s through Zoeticx’s Patient-Clarity Platform which connects disparate EHR records and enables medical system interoperability.

Mobile Devices, HIPAA Compliance

TruRecord client interfaces are supported on mobile and web interfaces, providing precise, personalized medication prescriptions. TruRecord accesses patient medical records via an on-demand, real time access from EHR / EMR systems. Without data duplication, TruRecord complies with all required secure patient privacy protection outlined by HIPAA.

“We built Zoeticx to help medical systems address interoperability, lower accidental deaths and bridge the gap between medical data and better patient outcomes,” said Thanh Tran, CEO, Zoeticx. “Today our goal is the same, but a shift toward an additional focus—adverse drug reactions. We are ushering in an era where we can leverage the fruits of DNA research to bring more precise and accurate prescriptions to those who rely on them. TruRecord takes the guess work out of drug interactions and patients by delivering security, peace of mind and accuracy.”

About Zoeticx

Zoeticx offers software solutions for the healthcare industry which are dedicated to improving patient outcomes, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  Additionally, as the Affordable Care Act continues to roll out, healthcare providers will face new challenges which arise whenever there is a transition from an old system of doing business to a new one. Zoeticx helps solve those challenges, allowing care providers to focus on what is most important, the patient. www.Zoeticx.com For additional information contact Glass Lantern PR at @glasslanternpr.com.

June 25, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Beaufort Memorial Hospital Selects ProVation® Order Sets, powered by UpToDate® Decision Support

MINNEAPOLIS, MN — Oct. 22, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Beaufort Memorial Hospital has selected its ProVation® Order Sets, powered by UpToDate® Decision Support, software as the hospital’s electronic order set solution.

ProVation Order Sets is an easily customizable order set authoring and management solution that provides flexible integration into clinical processes to streamline the delivery of standardized care for improved patient safety, outcomes, clinician performance and regulatory compliance. ProVation Order Sets is built upon ProVation Medical’s award-winning, clinician-designed technology platform. A key benefit is continuous updating of clinical content and medical evidence, including direct links to UpToDate, the resource of choice for more than 600,000 users worldwide.

Located in Beaufort, S.C., the 197-bed Beaufort Memorial Hospital is the largest hospital between Savannah, Ga. and Charleston, S.C. and home to more than 150 board certified or board-eligible physicians. Situated on the Atlantic Intracoastal Waterway, the hospital is one of the few hospitals in the country with its own emergency dock. Beaufort Memorial Hospital is a Duke Affiliate in heart and cancer and is Joint Commission-accredited.

“Beaufort Memorial Hospital is dedicated to delivering superior healthcare services to the communities it serves,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health Clinical Solutions. “We are pleased that they have selected ProVation Order Sets, powered by UpToDate Decision Support, to further this mission and provide evidence-based medicine at the point of care.”

About ProVation Medical

ProVation® Medical provides procedure documentation and clinical decision support solutions for hospitals and Ambulatory Surgery Centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage and image printing costs and deliver a high Return on Investment (ROI). ProVation® Order Sets, powered by UpToDate Decision Support, put evidence-based healthcare into practice by establishing and maintaining standards of care.

ProVation® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

November 20, 2012 I Written By

Datapharm Australia Selects Merge eClinical OS(TM) for Enterprise-Wide Electronic Data Capture

Solution Provides Comprehensive Suite of EDC Tools; Flexibility to Mix and Match Features

CHICAGO, Oct. 4, 2012 (GLOBE NEWSWIRE) — Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Datapharm Australia Pty Ltd. has selected Merge’s eClinical OS™ solution to bring EDC in-house and provide control of electronic case report form (eCRF) creation and mid-study adjustments.

“We’ve seen an increase in the number of our clients’ studies requiring EDC. Previously, we outsourced EDC projects to a third party vendor to handle eCRF setup,” explained Dr. Helen Allars, Managing Director at Datapharm Australia. “We found that we spent more time and resources managing this process and dealing with support issues. This approach also lacked the flexibility and control for mid-study changes.”

In 2010, Datapharm began an extensive EDC vendor evaluation, which included 14 vendors who could offer in-licensing of software for use across an enterprise, also referred to as technology transfer. Datapharm’s evaluation criteria consisted of a comprehensive suite of EDC tools, time to deployment, and overall costs associated with technology transfer.

“eClinical OS provided all the EDC features we needed – such as 21 CFR Part 11 and CDISC compliance, Hybrid/DDE, CRF library, reporting, data upload and exporting, medical coding, and monitoring tools – as well the opportunity to add patient reported outcomes, interactive response, randomization and inventory management if a particular study called for it,” continued Allars. “We were most impressed with how intuitive and flexible the system is, whether we are creating eCRFs or even making mid-study changes.”

“Companies that are bringing our solution in-house are doing so because they recognize that eClinical OS provides a strategic tool in their pursuit to provide more efficient, cost-effective clinical trials services,” said Justin Dearborn, President of Merge Healthcare. “Datapharm has taken the first critical step to yield the greatest efficiencies and financial rewards of using our eClinical technologies to simplify and accelerate the way they perform clinical trials.”

Merge eClinical OS is a unified platform delivering end-to-end study support. Clinical trial capabilities can be mixed and matched to build a solid foundation for each trial environment, and features and services can be added as needed, directly from within the system. As a single, web-based solution, it has the flexibility to support trials in any phase, and captures any type of data, from any source, over any modality. Merge eClinical OS also has the scalability to grow if a trial increases in size, number or complexity.

About Merge Healthcare

Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.

About Datapharm Australia

Datapharm Australia is Australia’s most experienced Full Service Contract Research Organization (CRO), celebrating 25 years in 2012. Services include: clinical trial management, set-up, monitoring, data management, statistical analysis and programming, medical writing, pharmacovigilance and auditing for Phase I to IV studies in over 35 therapeutic areas since 1987. Datapharm aims to provide clients with the best cost-effective, quality outcomes. For more information, visit DatapharmAustralia.com.

November 13, 2012 I Written By

Rochester General Health System Selects ProVation® Order Sets, powered by UpToDate® Decision Support

MINNEAPOLIS, MN — Aug. 21, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Rochester General Health System has selected its ProVation® Order Sets, powered by UpToDate® Decision Support, software as its electronic order set solution.

ProVation Order Sets is an easily customizable order set authoring and management solution that provides flexible integration into clinical processes to streamline the delivery of standardized care for improved patient safety, outcomes, clinician performance and regulatory compliance. ProVation Order Sets is built upon ProVation Medical’s award-winning, clinician-designed technology platform. A key benefit is continuous updating of clinical content and medical evidence, including direct links to UpToDate, the resource of choice for more than 600,000 users worldwide.

Located in Rochester, NY, Rochester General Health System is one of the fastest growing health systems in western and central New York State and is the only area health system to be rated by SDI as one of the Top 100 Integrated Health Networks in the U.S. It includes eight clinically integrated affiliates delivering comprehensive healthcare services, including Rochester General Hospital, Newark-Wayne Community Hospital, Hill Haven Assisted Living and Nursing Rehabilitation Center, DeMay Living Center, Rochester General Medical Group, Behavioral Health Network, Independent Living for Seniors, and RGHS Ambulatory Services Division. Rochester General Health System and its affiliates regularly earn national recognition for excellence in a range of clinical specialties.

“Rochester General Health System has a reputation for providing medical excellence,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health Clinical Solutions. “We are pleased they have selected ProVation Order Sets, powered by UpToDate Decision Support, to provide its clinicians with point-of-care access to evidence-based order sets.”

About ProVation Medical

ProVation® Medical provides procedure documentation and clinical decision support solutions for hospitals and Ambulatory Surgery Centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage and image printing costs and deliver a high Return on Investment (ROI). ProVation® Order Sets, powered by UpToDate Decision Support, puts evidence-based healthcare into practice by establishing and maintaining standards of care.

ProVation® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

September 18, 2012 I Written By

Windsor Health Group Selects MedHOK’s Single Platform for Care, Quality and Compliance for Clinical and Compliance Programs

TAMPA, Fla. – August 7, 2012 – Windsor Health Group and MedHOK, one of the healthcare industry’s fastest growing software companies, announced today that Windsor’s Medicare Advantage business, Windsor Health Plan, Inc., will deploy MedHOK’s single platform for care, quality and compliance to proactively close care gaps, enhance care management, improve Star scores and ensure compliance.  In doing so, Windsor is positioning itself to succeed in the rapidly changing healthcare environment that is emphasizing care and quality outcomes.

MedHOK offers fully NCQA certified software for HEDIS®, Pay for Performance and Disease Management performance measures. The company has more than 18 million lives in production and is on track to double this number within the year.

Nashville-based Windsor Health Plan, Inc., which provides Medicare Advantage and standalone Part D prescription drug plans for more than 157,000 Americans, will use MedHOK’s platform  to bolster care management quality for its members across 28 states:

  • MedHOK’s 360Member™ solution to increase its commitment to member-focused care
  • Utilization Management
  • Pharmacy Coverage Determinations and Redeterminations
  • Case and Disease Management
  • Predictive modeling and stratification
  • Part C and Part D Star improvement, quality and care gap closure
  • Pay for Performance
  • Grievances
  • Appeals
  • CMS Complaint Tracking Modules (CTMs) and general complaints
  • Independent Review Entity and external appeals
  • Correspondence/fulfillment, dashboard, reporting and audit functionality

“Windsor Health Plan and our employees have as our highest priority to ensure that our members receive the best quality of care available in the markets we serve.  Our strategy is to continue to invest in comprehensive clinical and member management systems like MedHOK that help improve quality and virtually every facet of the user experience for both our members and providers alike. We know that future success depends on constantly driving quality improvement and providing excellent service that our members expect and deserve,” said Michael A. Muchnicki, Chief Executive Officer of Windsor Health Group.

MedHOK’s integrated care management, quality and compliance platform facilitates improved clinical outcomes and care coordination while enhancing quality measures, compliance and financial performance. It accomplishes this by:

  • Providing real-time access to Star, HEDIS, pay-for-performance (P4P), and proprietary quality and performance measures, helping plans and providers to accurately monitor in real-time the data they need to achieve and maintain high quality ratings.
  • Triggering interventions when care gaps are identified, in particular for patients with multiple co-morbidities and chronic conditions.
  • Utilizing predictive analytics models to generate profiles based on clinical, quality and financial data for member, provider and local populations.
  • Calculating risk scores for every member, enabling timely predictions of those at the highest risk for more accurate forecasting of care costs and utilization.
  • Continuously monitoring for and addressing regulatory changes from CMS and state Medicaid agencies, ensuring clients stay ahead of the compliance curve.

“With the passage of health reform, all lines of business will see revenue directly tied to care, quality and compliance outcomes.  Health plans will need to deploy the right technologies that enable continuous monitoring of key care and performance measures,” said Anil Kottoor, president and CEO, MedHOK. “MedHOK’s single platform for care, quality and compliance is built for health plans and other entities seeking to succeed in this new rigorous, results-oriented environment.  We are proud to partner with Windsor to meet their future needs.”

About MedHOK

Tampa, Fla.-based MedHOK has more than 18 million lives in production and expects to double that number in 2012, making it one of the healthcare industry’s fastest-growing software companies. It offers a cloud-based integrated software platform for care management, quality and compliance that enables physicians, ACOs, PCMHs, payers and TPAs to manage and measure care against national quality standards for optimal outcomes. Its innovative modular software helps healthcare organizations meet quality, care and compliance objectives across business lines by facilitating real-time information sharing with all stakeholders to address disease management and care coordination, clinical quality and utilization review, and quality and financial measures. ICD-10 compliant, HIE-ready and securely accessible on any device, the MedHOK platform is user-friendly, rapidly deployed and easily configurable for a low total cost of ownership and rapid return on investment. It holds 2012 HEDIS®, Pay for Performance and Disease Management performance measures certification.

About Windsor

Windsor Health GroupSM refers to Windsor Health Group, Inc., an insurance holding company and its operating subsidiaries, which include Windsor Health Plans, Inc. (WHP), and Sterling Life Insurance Company (SLIC). WHG, through WHP and SLIC, serves more than 230,000 Americans with a variety of insurance offerings for the senior population. WHG is a subsidiary of Munich Health North America, Inc., which is a subsidiary of Munich Reinsurance Company (Munich Re), one of the world’s leading reinsurers.

August 22, 2012 I Written By

Wolters Kluwer Health’s Sentri7® Patient Surveillance Software Receives High Marks in Two Recent KLAS Reports

Bellevue, Wash. — Aug. 21, 2012— Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that a recent KLAS report found that 92% of customers who had purchased its Sentri7® Infection Prevention* patient surveillance technology would buy again. Infection Control Systems 2012: Breaking Barriers and Getting Value also reported that Sentri7 Infection Prevention had earned an overall performance score of 88.5% and rated well in all functional areas with no gaps in satisfaction scores.

Another KLAS report, Clinical Decision Support 2011: Understanding the Impact, rated Pharmacy OneSource Sentri7 as having the highest impact on quality outcomes when compared to other types of clinical decision support tools currently being used in the healthcare market. The product achieved a positive impact score of greater than 80%.

Sentri7® is a web-based platform that aggregates, monitors and delivers patient data in real-time from disparate hospital information systems to assist providers in delivering optimum patient care, reducing drug costs, and improving outcomes. The smart logic contained within the electronic surveillance system allows for a rules-based approach to infection prevention that targets specific conditions to support hospital quality initiatives.

For the Infection Control Systems report, KLAS, an independent healthcare IT vendor research firm that recognizes healthcare vendors for their leadership in working with customers to ensure satisfaction, spoke with 119 providers managing infection control processes on paper and 202 currently using an infection control system. The research specifically focused on system performance for National Healthcare Safety Network (NHSN) reporting, analytics, interfacing and ability to enhance the efforts of infection prevention professionals.

For the Clinical Decision Support report, KLAS interviewed 404 providers to rate the performance of a variety of decision support tools including care plans, diagnostic decision support tools, disease reference tools, drug databases, drug reference tools, order sets and surveillance tools. The impact was measured by asking providers to rate the influence the various tools had on clinical decisions and standardizing care.

“The stakes are high for patient safety. Using electronic surveillance technology is a critical strategy for hospitals seeking to eliminate healthcare-associated infections and maximize reimbursement in the era of value-based purchasing,” said Tim Gibbons, Vice President & General Manager, Pharmacy OneSource, Wolters Kluwer Health Clinical Solutions. “We are pleased to have received these high scores from customers and believe it demonstrates our commitment to delivering technology to help them identify potential HAI earlier and provide treatment options to reduce overall healthcare cost.  This truly shapes the future of healthcare.”

About Pharmacy OneSource

Pharmacy OneSource® is healthcare’s #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services.

Pharmacy OneSource is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and be counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Founded in 1996, KLAS staff and advisory board average 25 years of healthcare information technology experience. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

I Written By

Simply Healthcare Selects MedHOK to Enhance Quality Improvement Initiatives

TAMPA, Fla. – Feb. 28, 2012 – MedHOK, one of the healthcare industry’s fastest growing companies providing cloud-based software, announced today that Simply Healthcare will deploy its integrated care management, quality and compliance platform to proactively enhance its quality improvement initiatives. In doing so, Simply Healthcare is well positioned to respond to Centers for Medicare & Medicaid Services (CMS) and the Florida Agency for Health Care Administration (AHCA) efforts to enhance quality outcomes and reduce costs. MedHOK, which offers fully NCQA certified software for HEDIS®, has more than 15 million live in production and is on track to reach 30 million within the year, making it one of the healthcare industry’s leading software companies.

Simply Healthcare is a Coral Gables, Fla.-based HMO that serves Florida’s Medicaid and Healthy Kids populations and Medicare Advantage members. It will leverage the MedHOK platform for annual HEDIS filings, as well as to identify and remediate any care gaps and improve outcomes going forward.

“We appreciate the expertise MedHOK brings to the table and their collaborative approach to achieving our goals,” said Dwight Pattison, director of quality management, Simply Healthcare.

MedHOK’s integrated care management, quality and compliance platform facilitates improved clinical outcomes and care coordination while enhancing quality measures, compliance and financial performance. It accomplishes this by:

  • Providing real-time access to Star, HEDIS, pay-for-performance (P4P), and proprietary quality and performance measures, helping providers accurately monitor in real-time the data they need to achieve and maintain high quality ratings
  • Triggering interventions when care gaps are identified, in particular for patients with multiple comorbidities and chronic conditions
  • Utilizing predictive analytics models to generate profiles based on clinical, quality and financial data for member, provider and local populations
  • Calculating risk scores for every member, enabling timely predictions of those at the highest risk for more accurate forecasting of care costs and utilization
  • Continuously monitoring for and addressing regulatory changes from CMS and state Medicaid agencies, ensuring clients stay ahead of the compliance curve

“To thrive into today’s healthcare environment, health plans must be committed to improving quality and reducing costs,” said Anil Kottoor, president and CEO, MedHOK. “By leveraging the power of our integrated care, quality and compliance platform, they can eliminate the year-end HEDIS fire drills through continuous performance monitoring and streamlined workflows that mitigate care gaps.”

About MedHOK

Tampa, Fla.-based MedHOK has more than 15 million lives in production and expects to double that number in 2012, making it one of the healthcare industry’s fastest-growing software companies. It offers a cloud-based integrated software platform for care management, quality and compliance that enables physicians, ACOs, PCMHs, payers and TPAs to manage and measure care against national quality standards for optimal outcomes. Its innovative modular software helps healthcare organizations meet quality, care and compliance objectives across business lines by facilitating real-time information sharing with all stakeholders to address disease management and care coordination, clinical quality and utilization review, and quality and financial measures. ICD-10 compliant, HIE-ready and securely accessible on any device, the MedHOK platform is user-friendly, rapidly deployed and easily configurable for a low total cost of ownership and rapid return on investment. The company’s 360Measures holds full 2012 HEDIS® certification.

March 30, 2012 I Written By